{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:59:32Z","timestamp":1790913572317,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28605-2","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T07:33:31Z","timestamp":1765092811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Machine learning guided virtual screening of FDA approved drugs targeting GSK-3\u03b2 in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Bandral Sunil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavana Gowda Hosur","family":"Dinesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Ganjipete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohankumar","family":"Ramar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodar Nayak","family":"Ammunje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaraj","family":"Kunjiappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumarappan","family":"Chidambaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuraman","family":"Pavadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"28605_CR1","unstructured":"Kumar, B. S. et al. Alzheimer\u2019s Disease Protein Targets: Comprehensive Review and Future Directions. (2024)."},{"key":"28605_CR2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"MA Better","year":"2023","unstructured":"Better, M. A. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 19, 1598\u20131695 (2023).","journal-title":"Alzheimers Dement."},{"key":"28605_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3233\/JAD-160108","volume":"53","author":"SW Suh","year":"2016","unstructured":"Suh, S. W. et al. Impacts of illiteracy on the risk of dementia: a global health perspective. J. Alzheimer\u2019s Disease. 53, 731\u2013741 (2016).","journal-title":"J. Alzheimer\u2019s Disease"},{"key":"28605_CR4","first-page":"1097","volume":"10","author":"HW Seo","year":"2025","unstructured":"Seo, H. W., Ryu, S., Han, S. Y., Lee, S. H. & Chung, J. H. Cochlear implantation is associated with reduced incidence of dementia in severe hearing loss. Ear Hear. 10, 1097 (2025).","journal-title":"Ear Hear."},{"key":"28605_CR5","doi-asserted-by":"publisher","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","volume":"12","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. The global macroeconomic burden of alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories. Lancet Global Health. 12, e1534\u2013e1543 (2024).","journal-title":"Lancet Global Health"},{"key":"28605_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JAD-179901","volume":"64","author":"J Cummings","year":"2018","unstructured":"Cummings, J., Ritter, A. & Zhong, K. Clinical trials for disease-modifying therapies in Alzheimer\u2019s disease: a primer, lessons learned, and a blueprint for the future.. J. Alzheimer\u2019s disease.\u00a0 64, S3\u2013S22 (2018).","journal-title":"J. Alzheimer\u2019s disease.\u00a0"},{"key":"28605_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/biomedicines7040097","volume":"7","author":"KG Yiannopoulou","year":"2019","unstructured":"Yiannopoulou, K. G., Anastasiou, A. I., Zachariou, V. & Pelidou, S. H. Reasons for failed trials of disease-modifying treatments for alzheimer disease and their contribution in recent research. Biomedicines 7, 97 (2019).","journal-title":"Biomedicines"},{"key":"28605_CR8","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","volume":"90","author":"SJ Andrews","year":"2023","unstructured":"Andrews, S. J. et al. The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. EBioMedicine 90, 104511 (2023).","journal-title":"EBioMedicine"},{"key":"28605_CR9","doi-asserted-by":"publisher","first-page":"11057","DOI":"10.1039\/D3RA08333K","volume":"14","author":"AE Abdallah","year":"2024","unstructured":"Abdallah, A. E. Review on anti-alzheimer drug development: approaches, challenges and perspectives. RSC Adv. 14, 11057\u201311088 (2024).","journal-title":"RSC Adv."},{"key":"28605_CR10","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.14235128","author":"T Gurud","year":"2024","unstructured":"Gurud, T. et al. Lecanemab: A Novel Therapeutic Approach for Alzheimer\u2019s Disease. International J. Sci. Res. Technology https:\/\/doi.org\/10.5281\/zenodo.14235128 (2024).","journal-title":"International J. Sci. Res. Technology"},{"key":"28605_CR11","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon, S. Aducanumab: first approval. Drugs 81, 1437\u20131443 (2021).","journal-title":"Drugs"},{"key":"28605_CR12","unstructured":"Climan, A. The Aducanumab Controversy: Accelerated FDA Approval Leads to Agency Distrust."},{"key":"28605_CR13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41467-021-21330-0","volume":"12","author":"S Rodriguez","year":"2021","unstructured":"Rodriguez, S. et al. Machine learning identifies candidates for drug repurposing in alzheimer\u2019s disease. Nat. Commun. 12, 1033 (2021).","journal-title":"Nat. Commun."},{"key":"28605_CR14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41467-025-56690-4","volume":"16","author":"JL Cummings","year":"2025","unstructured":"Cummings, J. L. et al. Drug repurposing for alzheimer\u2019s disease and other neurodegenerative disorders. Nat. Commun. 16, 1755 (2025).","journal-title":"Nat. Commun."},{"key":"28605_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10462-024-11041-5","volume":"58","author":"S Toumaj","year":"2024","unstructured":"Toumaj, S., Heidari, A. & Shahhosseini, R. Jafari Navimipour, N. Applications of deep learning in alzheimer\u2019s disease: A systematic literature review of current trends, methodologies, challenges, innovations, and future directions. Artif. Intell. Rev. 58, 44 (2024).","journal-title":"Artif. Intell. Rev."},{"key":"28605_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-021-00951-z","volume":"14","author":"J Fang","year":"2022","unstructured":"Fang, J. et al. Artificial intelligence framework identifies candidate targets for drug repurposing in alzheimer\u2019s disease. Alzheimers Res. Ther. 14, 7 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"28605_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2025.108604","author":"NA Zulhafiz","year":"2025","unstructured":"Zulhafiz, N. A., Teoh, T. C., Chin, A. V. & Chang, S. W. Drug repurposing using artificial intelligence, molecular docking, and hybrid approaches: A comprehensive review in general diseases vs Alzheimer\u2019s disease. Comput. Methods Progr. Biomed. https:\/\/doi.org\/10.1016\/j.cmpb.2025.108604 (2025).","journal-title":"Comput. Methods Progr. Biomed."},{"key":"28605_CR18","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.csbj.2023.02.004","volume":"21","author":"X Pan","year":"2023","unstructured":"Pan, X. et al. AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders. Comput. Struct. Biotechnol. J. 21, 1533\u20131542 (2023).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"28605_CR19","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1002\/alz.13412","volume":"19","author":"RJ Borchert","year":"2023","unstructured":"Borchert, R. J. et al. Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review. Alzheimer\u2019s Dement. 19, 5885\u20135904 (2023).","journal-title":"Alzheimer\u2019s Dement."},{"key":"28605_CR20","doi-asserted-by":"publisher","first-page":"31901","DOI":"10.1038\/s41598-025-17733-4","volume":"15","author":"D Hanumanthappa","year":"2025","unstructured":"Hanumanthappa, D. et al. Computational insights and experimental breakthroughs in identifying next-generation acetylcholinesterase inhibitors. Sci. Rep. 15, 31901 (2025).","journal-title":"Sci. Rep."},{"key":"28605_CR21","first-page":"s00441788657","volume":"82","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Revolutionizing early alzheimer\u2019s disease and mild cognitive impairment diagnosis: a deep learning MRI meta-analysis. Arq. Neuropsiquiatr. 82, s00441788657 (2024).","journal-title":"Arq. Neuropsiquiatr."},{"key":"28605_CR22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.2174\/1381612829666230428110542","volume":"29","author":"AV Srivathsa","year":"2023","unstructured":"Srivathsa, A. V. et al. A review on artificial intelligence approaches and rational approaches in drug discovery. Curr. Pharm. Design. 29, 1180\u20131192 (2023).","journal-title":"Curr. Pharm. Design"},{"key":"28605_CR23","doi-asserted-by":"publisher","first-page":"1443865","DOI":"10.3389\/fninf.2024.1443865","volume":"18","author":"AP P\u00e9rez-Gonz\u00e1lez","year":"2024","unstructured":"P\u00e9rez-Gonz\u00e1lez, A. P. et al. The ROSMAP project: aging and neurodegenerative diseases through omic sciences. Front. Neuroinformatics. 18, 1443865 (2024).","journal-title":"Front. Neuroinformatics"},{"key":"28605_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/pr9020264","volume":"9","author":"TJ Anastasio","year":"2021","unstructured":"Anastasio, T. J. Predicting the potency of anti-Alzheimer\u2019s drug combinations using machine learning. Processes 9, 264 (2021).","journal-title":"Processes"},{"key":"28605_CR25","first-page":"571","volume":"6","author":"P Parasuraman","year":"2014","unstructured":"Parasuraman, P., Suresh, R. & Premnath, D. Balancing anti-amyloid and anti-cholinesterase capacity in a single chemical entity: in Silico drug design. Int. J. Pharm. Pharm. Sci. 6, 571 (2014).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"28605_CR26","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.4103\/0366-6999.220313","volume":"130","author":"XL Wu","year":"2017","unstructured":"Wu, X. L., Pi\u00f1a-Crespo, J., Zhang, Y. W., Chen, X. C. & Xu, H. X. Tau-mediated neurodegeneration and potential implications in diagnosis and treatment of alzheimer\u2019s disease. Chin. Med. J. 130, 2978\u20132990 (2017).","journal-title":"Chin. Med. J."},{"key":"28605_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel, C. J., Wilson, C. A., Lee, V. M. Y. & Klein, P. GSK-3\u03b1 regulates production of alzheimer\u2019s disease amyloid-\u03b2 peptides. Nature 423, 435\u2013439 (2003).","journal-title":"Nature"},{"key":"28605_CR28","first-page":"487","volume":"12","author":"RR Rajeshkumar","year":"2022","unstructured":"Rajeshkumar, R. R. et al. Graph theoretical network analysis, in Silico exploration, and validation of bioactive compounds from cynodon dactylon as potential neuroprotective agents against \u03b1-synuclein. BioImpacts: BI. 12, 487 (2022).","journal-title":"BioImpacts: BI"},{"key":"28605_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1517\/17460441.2010.492827","volume":"5","author":"C Nantasenamat","year":"2010","unstructured":"Nantasenamat, C., Isarankura-Na-Ayudhya, C. & Prachayasittikul, V. Advances in computational methods to predict the biological activity of compounds. Expert Opin. Drug Discov. 5, 633\u2013654 (2010).","journal-title":"Expert Opin. Drug Discov."},{"key":"28605_CR30","doi-asserted-by":"crossref","unstructured":"Vastrad, C. Predictive comparative QSAR analysis of As 5-nitofuran-2-YL derivatives myco bacterium tuberculosis H37RV inhibitors bacterium tuberculosis H37RV inhibitors. arXiv preprint arXiv:1312.2841 (2013).","DOI":"10.5121\/hiij.2013.2404"},{"key":"28605_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","volume":"10","author":"H Moriwaki","year":"2018","unstructured":"Moriwaki, H., Tian, Y. S., Kawashita, N. & Takagi, T. Mordred: a molecular descriptor calculator. J. Cheminform. 10, 4 (2018).","journal-title":"J. Cheminform."},{"key":"28605_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gaitpost.2021.06.017","volume":"89","author":"J Chong","year":"2021","unstructured":"Chong, J., Tjurin, P., Niemel\u00e4, M., J\u00e4ms\u00e4, T. & Farrahi, V. Machine-learning models for activity class prediction: A comparative study of feature selection and classification algorithms. Gait Posture. 89, 45\u201353 (2021).","journal-title":"Gait Posture"},{"key":"28605_CR33","first-page":"1","volume":"50","author":"J Li","year":"2017","unstructured":"Li, J. et al. Feature selection: A data perspective. ACM Comput. Surv. (CSUR). 50, 1\u201345 (2017).","journal-title":"ACM Comput. Surv. (CSUR)"},{"key":"28605_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s13721-021-00326-2","volume":"10","author":"GIB Janairo","year":"2021","unstructured":"Janairo, G. I. B., Yu, D. E. C. & Janairo, J. I. B. A machine learning regression model for the screening and design of potential SARS-CoV-2 protease inhibitors. Netw. Model. Anal. Health Inf. Bioinf. 10, 51 (2021).","journal-title":"Netw. Model. Anal. Health Inf. Bioinf."},{"key":"28605_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13321-023-00799-5","volume":"16","author":"J Wu","year":"2024","unstructured":"Wu, J. et al. Large-scale comparison of machine learning methods for profiling prediction of kinase inhibitors. J. Cheminform. 16, 13 (2024).","journal-title":"J. Cheminform."},{"key":"28605_CR36","unstructured":"Rafi, T. H. & Farhan, F. in International Conference on Soft Computing and Pattern Recognition. 256\u2013265 (Springer)."},{"key":"28605_CR37","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1021\/acs.jmedchem.9b00867","volume":"63","author":"F Miljkovic","year":"2019","unstructured":"Miljkovic, F., Rodriguez-Perez, R. & Bajorath, J. r. Machine learning models for accurate prediction of kinase inhibitors with different binding modes. J. Med. Chem. 63, 8738\u20138748 (2019).","journal-title":"J. Med. Chem."},{"key":"28605_CR38","volume-title":"A review and comparison of methods for detecting outliers in univariate data sets","author":"S Seo","year":"2006","unstructured":"Seo, S. A review and comparison of methods for detecting outliers in univariate data sets (University of Pittsburgh, 2006)."},{"key":"28605_CR39","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1021\/ci025503y","volume":"42","author":"BA Tounge","year":"2002","unstructured":"Tounge, B. A., Pfahler, L. B. & Reynolds, C. H. Chemical information based scaling of molecular descriptors: a universal chemical scale for library design and analysis. J. Chem. Inf. Comput. Sci. 42, 879\u2013884 (2002).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"28605_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41598-023-49839-y","volume":"14","author":"S Kunjiappan","year":"2024","unstructured":"Kunjiappan, S. et al. Optimization of ultrasound-aided extraction of bioactive ingredients from vitis vinifera seeds using RSM and ANFIS modeling with machine learning algorithm. Sci. Rep. 14, 1219 (2024).","journal-title":"Sci. Rep."},{"key":"28605_CR41","doi-asserted-by":"publisher","first-page":"617327","DOI":"10.3389\/fnbot.2020.617327","volume":"14","author":"L Deng","year":"2020","unstructured":"Deng, L. et al. Artificial intelligence-based application to explore inhibitors of neurodegenerative diseases. Front. Neurorobotics. 14, 617327 (2020).","journal-title":"Front. Neurorobotics."},{"key":"28605_CR42","doi-asserted-by":"publisher","first-page":"12445","DOI":"10.1080\/07391102.2023.2175263","volume":"41","author":"R Choudhary","year":"2023","unstructured":"Choudhary, R. et al. Machine learning facilitated structural activity relationship approach for the discovery of novel inhibitors targeting EGFR. J. Biomol. Struct. Dynamics. 41, 12445\u201312463 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"28605_CR43","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/21642583.2014.956265","volume":"2","author":"K Fawagreh","year":"2014","unstructured":"Fawagreh, K., Gaber, M. M. & Elyan, E. Random forests: from early developments to recent advancements. Syst. Sci. Control Engineering: Open. Access. J. 2, 602\u2013609 (2014).","journal-title":"Syst. Sci. Control Engineering: Open. Access. J."},{"key":"28605_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"28605_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.procs.2020.09.037","volume":"176","author":"M Azad","year":"2020","unstructured":"Azad, M., Chikalov, I. & Moshkov, M. Representation of knowledge by decision trees for decision tables with multiple decisions. Procedia Comput. Sci. 176, 653\u2013659 (2020).","journal-title":"Procedia Comput. Sci."},{"key":"28605_CR46","unstructured":"Hoover, D. N. & Chen, Z. in COMPASS\u201995 Proceedings of the Tenth Annual Conference on Computer Assurance Systems Integrity, Software Safety and Process Security\u2019. 97\u2013108 (IEEE)."},{"key":"28605_CR47","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.3390\/app12104851","volume":"12","author":"H Dabiri","year":"2022","unstructured":"Dabiri, H., Farhangi, V., Moradi, M. J., Zadehmohamad, M. & Karakouzian, M. Applications of decision tree and random forest as tree-based machine learning techniques for analyzing the ultimate strain of spliced and non-spliced reinforcement bars. Appl. Sci. 12, 4851 (2022).","journal-title":"Appl. Sci."},{"key":"28605_CR48","doi-asserted-by":"publisher","first-page":"112824","DOI":"10.1016\/j.eswa.2019.112824","volume":"139","author":"M Abdel-Basset","year":"2020","unstructured":"Abdel-Basset, M., El-Shahat, D., El-Henawy, I., De Albuquerque, V. H. C. & Mirjalili, S. A new fusion of grey Wolf optimizer algorithm with a two-phase mutation for feature selection. Expert Syst. Appl. 139, 112824 (2020).","journal-title":"Expert Syst. Appl."},{"key":"28605_CR49","doi-asserted-by":"publisher","DOI":"10.1063\/5.0219478","author":"B Kim","year":"2024","unstructured":"Kim, B., Seo, S. H., Oh, D. K. & Na, Y. S. Classification of the L-, H-mode, and plasma-free state: convolutional neural networks and variational autoencoders on the edge reflectometer for KSTAR. Review Sci. Instrum. https:\/\/doi.org\/10.1063\/5.0219478 (2024).","journal-title":"Review Sci. Instrum."},{"key":"28605_CR50","doi-asserted-by":"publisher","first-page":"855","DOI":"10.18576\/amis\/140513","volume":"14","author":"M Sakr","year":"2020","unstructured":"Sakr, M., Saber, A., Abo-Seida, M., Keshk, A. & O. & Machine learning for breast cancer classification using k-star algorithm. Appl. Math. Inform. Sci. 14, 855\u2013863 (2020).","journal-title":"Appl. Math. Inform. Sci."},{"key":"28605_CR51","unstructured":"Tomaszewska, A. M., Yanushkevich, S. N. & Shmerko, V. P. in Proceedings 32nd IEEE International Symposium on Multiple-Valued Logic. 209\u2013215 (IEEE).2002"},{"key":"28605_CR52","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.3390\/su13115877","volume":"13","author":"RM Adnan","year":"2021","unstructured":"Adnan, R. M., Jaafari, A., Mohanavelu, A., Kisi, O. & Elbeltagi, A. Novel ensemble forecasting of streamflow using locally weighted learning algorithm. Sustainability 13, 5877 (2021).","journal-title":"Sustainability"},{"key":"28605_CR53","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s42256-021-00332-z","volume":"3","author":"RD King","year":"2021","unstructured":"King, R. D., Orhobor, O. I. & Taylor, C. C. Cross-validation is safe to use. Nat. Mach. Intell. 3, 276\u2013276 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"28605_CR54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4258\/hir.2021.27.3.189","volume":"27","author":"I Tougui","year":"2021","unstructured":"Tougui, I., Jilbab, A. & El Mhamdi, J. Impact of the choice of cross-validation techniques on the results of machine learning-based diagnostic applications. Healthc. Inf. Res. 27, 189\u2013199 (2021).","journal-title":"Healthc. Inf. Res."},{"key":"28605_CR55","unstructured":"Anguita, D., Ghelardoni, L., Ghio, A., Oneto, L. & Ridella, S. in Esann 441\u2013446 . 2012"},{"key":"28605_CR56","doi-asserted-by":"publisher","first-page":"101379","DOI":"10.1016\/j.xcrm.2023.101379","volume":"5","author":"F Cheng","year":"2024","unstructured":"Cheng, F. et al. Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer\u2019s disease. Cell Rep. Med. 5, 101379 (2024).","journal-title":"Cell Rep. Med."},{"key":"28605_CR57","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s11030-022-10516-3","volume":"27","author":"J Chandrasekaran","year":"2023","unstructured":"Chandrasekaran, J. et al. Computational design of PD-L1 small molecule inhibitors for cancer therapy. Mol. Diversity. 27, 1633\u20131644 (2023).","journal-title":"Mol. Diversity"},{"key":"28605_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/2211352517666190405155505","volume":"18","author":"P Pavadai","year":"2020","unstructured":"Pavadai, P. et al. Synthesis of piperidine-4-one derivative containing dipeptide: an acetyl cholinesterase and \u03b2-secretase inhibitor. Anti-infective Agents. 18, 160\u2013168 (2020).","journal-title":"Anti-infective Agents"},{"key":"28605_CR59","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/life13061298","volume":"13","author":"AC Gade","year":"2023","unstructured":"Gade, A. C., Murahari, M., Pavadai, P. & Kumar, M. S. Virtual screening of a marine natural product database for in Silico identification of a potential acetylcholinesterase inhibitor. Life 13, 1298 (2023).","journal-title":"Life"},{"key":"28605_CR60","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.3390\/molecules28114541","volume":"28","author":"S Vellur","year":"2023","unstructured":"Vellur, S. et al. An in Silico molecular modelling-based prediction of potential Keap1 inhibitors from hemidesmus indicus (L.) R. Br. against oxidative-stress-induced diseases. Molecules 28, 4541 (2023).","journal-title":"Molecules"},{"key":"28605_CR61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/a-0650-3979","volume":"69","author":"P Theivendren","year":"2019","unstructured":"Theivendren, P. et al. Graph theoretical analysis, insilico modeling and formulation of pyrimidine nanoparticles as p38\u03b1 MAP kinases inhibitors: A quantitative proteomics approach. Drug Res. 69, 100\u2013110 (2019).","journal-title":"Drug Res."},{"key":"28605_CR62","doi-asserted-by":"publisher","first-page":"100233","DOI":"10.1016\/j.dscb.2025.100233","volume":"18","author":"UL Rakesh","year":"2025","unstructured":"Rakesh, U. L. et al. Computational discovery of plant-derived flavonoids as potential amyloid-\u03b2 fibril disaggregating agents for alzheimer\u2019s disease. Brain Disorders. 18, 100233 (2025).","journal-title":"Brain Disorders"},{"key":"28605_CR63","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/cmdc.200600155","volume":"1","author":"U Norinder","year":"2006","unstructured":"Norinder, U. & Bergstr\u00f6m, C. A. Prediction of ADMET properties. ChemMedChem: Chem. Enabling Drug Discovery. 1, 920\u2013937 (2006).","journal-title":"ChemMedChem: Chem. Enabling Drug Discovery"},{"key":"28605_CR64","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ddr.21460","volume":"79","author":"G Saravanan","year":"2018","unstructured":"Saravanan, G. et al. Design, graph theoretical analysis, density functionality theories, insilico modeling, synthesis, characterization and biological activities of novel thiazole fused Quinazolinone derivatives. Drug Dev. Res. 79, 260\u2013274 (2018).","journal-title":"Drug Dev. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28605-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:04:10Z","timestamp":1777406650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28605-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28605"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28605-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45762"}}